Literature DB >> 32985331

MiR-155-5p promotes renal interstitial fibrosis in obstructive nephropathy via inhibiting SIRT1 signaling pathway.

Zhan Wang1, Rui Chen2, Zheming Xu1, Wei Ru1, Hongjuan Tian1, Fan Yang1, Chang Tao1.   

Abstract

Protection against renal fibrosis is important for the management of obstructive nephropathy. We researched the roles and possible mechanism of miR-155-5p in renal interstitial fibrosis, which may provide a potential endogenous target for renal interstitial fibrosis in obstructive nephropathy. Herein, NRK-49F cells were transfected with miR-155-5p mimic, miR-155-5p inhibitor, SIRT1 plasmid and/or SIRT1 siRNA. The unilateral ureteral obstruction (UUO) model was built with male C57 black mice and administrated with SRT1720 by tail vein injection. Levels of miR-155-5p, SIRT1 and relative proteins (TGF-β1, α-SMA, Collage I and fibronectin) in NRK-49F cells or mice kidney tissues were measured with quantitative reverse transcription polymerase chain reaction or Western blot. The target gene of miR-155-5p was analyzed through TargetScan and dual-luciferase reporter assay. Mice kidney tissue was stained with Masson trichrome. It was found that miR-155-5p overexpression promoted the expressions of fibroblast related proteins expression and inhibited the SIRT1 expression in NRK-49F cells, while miR-155-5p silencing had an opposite effect. SIRT1 can bind with miR-155-5p. MiR-155-5p inhibited the level of SIRT1. Fibroblast related proteins were up-regulated by miR-155-5p and down-regulated by SIRT1 in NRK-49F cells, while the up-regulatory effect of miR-155-5p was reversed by SIRT1. MiR-155-5p expression was up-regulated and SIRT1 expression was down-regulated in the kidney tissue of UUO mice. SRT1720 attenuated the fiber deposition, up-regulated SIRT1 level and down-regulated the levels of fibroblast related proteins in UUO model mice. To conclude, miR-155-5p promotes renal interstitial fibrosis in obstructive nephropathy via inhibiting SIRT1 signaling pathway.

Entities:  

Keywords:  SIRT1; miR-155-5p; obstructive nephropathy; renal fibrosis; unilateral ureteral obstruction

Mesh:

Substances:

Year:  2020        PMID: 32985331     DOI: 10.1080/10799893.2020.1825491

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  4 in total

1.  MiR-155 deficiency protects renal tubular epithelial cells from telomeric and genomic DNA damage in cisplatin-induced acute kidney injury.

Authors:  Qing Yin; Ya-Jie Zhao; Wei-Jie Ni; Tao-Tao Tang; Yao Wang; Jing-Yuan Cao; Di Yin; Yi Wen; Zuo-Lin Li; Yi-Lin Zhang; Wei Jiang; Yue Zhang; Xiao-Yu Lu; Ai-Qing Zhang; Wei-Hua Gan; Lin-Li Lv; Bi-Cheng Liu; Bin Wang
Journal:  Theranostics       Date:  2022-06-06       Impact factor: 11.600

2.  Inhibition of miRNA-155 Alleviates High Glucose-Induced Podocyte Inflammation by Targeting SIRT1 in Diabetic Mice.

Authors:  Xiaolei Wang; Yanbin Gao; Wenming Yi; Yu Qiao; Hao Hu; Ying Wang; Yan Hu; Shuxin Wu; Hongfeng Sun; Taojing Zhang
Journal:  J Diabetes Res       Date:  2021-03-08       Impact factor: 4.011

Review 3.  Functional Role of miR-155 in the Pathogenesis of Diabetes Mellitus and Its Complications.

Authors:  Stanislovas S Jankauskas; Jessica Gambardella; Celestino Sardu; Angela Lombardi; Gaetano Santulli
Journal:  Noncoding RNA       Date:  2021-07-07

Review 4.  Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease.

Authors:  Claudia Tovar-Palacio; Lilia G Noriega; Adriana Mercado
Journal:  Nutrients       Date:  2022-02-03       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.